Pneumonectomy for Lung Metastases: Report of Ten Cases

J. M. H. Hendriks; B. van Putte; S. Romijn; J. van den Brande; J. B. Vermorken; P. E. van Schil

doi:10.1055/s-2003-37274

The Thoracic and Cardiovascular Surgeon, Table of Contents

Thorac Cardiovasc Surg 2003; 51(1): 38-41
DOI: 10.1055/s-2003-37274

Original Thoracic

Pneumonectomy for Lung Metastases:
Report of Ten Cases

J. M. H. Hendriks¹ , B. van Putte¹ , S. Romijn¹ , J. van den Brande¹ , J. B. Vermorken¹ , P. E. van Schil¹

¹Department of Thoracic and Vascular Surgery, University of Antwerp, Edegem, Belgium

Presented at the 11th Annual ERS Congress, September 22 - 26, 2001, Berlin, Germany

Abstract

All articles of this category

Abstract

Today, pulmonary resection for lung metastases is a widely accepted treatment if complete resection can be achieved. However, 5-year survival is only 40 %. Many patients develop recurrences, but some reports have demonstrated that salvage operations can result in a long-term survival. A resection of a complete lung or a resection of more than a lung is still controversial since procedure-related morbidity or mortality does not outweigh the survival benefit. We report on a series of 10 consecutive patients who underwent a primary pneumonectomy or an operation on the residual lung after pneumonectomy with curative intent for pulmonary metastases. 5 year survival rates for the 10 patients after pneumonectomy alone or with additional resection was 45 %, which was not significantly different from those who underwent a more minor resection with a 5-year survival of 39 % (p = 0.40). Since there is currently no alternative proven therapy for patients with isolated pulmonary metastases, a primary or completion pneumonectomy may be offered to selected patients as long as sufficient pulmonary reserve is present, and a complete resection can be achieved.

Key words

Lung metastases - thoracic surgery - pneumonectomy

Full Text

References

1 McCormack P, Bains M, Beattie E, Martini N. Pulmonary resection in metastatic carcinoma. Chest. 1978; 73 163-166
2 Pastorino U, Buyse M, Friedel G. et al . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry for Lung Metastases. J Thorac Cardiovasc Surg. 1997; 113 37-49
3 Hendriks J M, Romijn S, van Putte B. et al . Long-term results of surgical resection of lung metastases. Acta Chir Belg. 2001; 101 267-272
4 Pogrebniak H, Roth J, Steinberg S, Rosenberg S, Pass H. Reoperative pulmonary resection in patients with soft tissue sarcoma. Ann Thorac Surg. 1991; 52 197-203
5 Casson A G, Putnam J B, Natarajan G. et al . Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma. J Surg Oncol. 1991; 47 1-4
6 Hendriks J M, van Schil P E, Schrijvers D. Bilateral pulmonary resection for lung metastases: report of two cases. Eur J Surg Oncol. 1999; 25 552-553
7 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978; 76 832-839
8 Me G overn, Trastek V, Pairolero P, Payne W. Completion pneumonectomy: indications, complications and results. Ann Thorac Surg. 1988; 46 141-146
9 Putnam J. Douglas M, Natarajan G. Roth J. Extended resection of pulmonary metastases: is the risk justified?. Ann Thorac Surg. 1993; 55 1440-1446
10 Al-Kattan K, Goldstraw P. Completion pneumonectomy: indications and outcome. J Thorac Cardiovasc Surg. 1995; 110 1125-1129
11 Spaggiari L, Grunenwald H, Gerard Ph, Solli P, Le Chevalier Th. Pneumonectomy for lung metastases: indications, risks, and outcome. Ann Thorac Surg. 1998; 66 1930-1933
12 Koong H, Pastorino U, Ginsberg R. for the International Registry of Lung Metastases . Is there a role for pneumonectomy in pulmonary metastases?. Ann Thorac Surg. 1999; 68 2039-2043
13 Bernard A, Deschamps C, Allen M. et al . Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg. 2001; 121 1076-1082
14 van Geel A, Pastorino U, Jauch K. et al . Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 1996; 77 675-682
15 Kandioler D, Kromer E, Tuchler H. et al . Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg. 1998; 65 909-912
16 Jaklitsch M, Mery C, Lukanich J. et al . Sequential thoracic metastasectomy prolongs survival by reestablishing local control within the chest. J Thorac Cardiovasc Surg. 2001; 121 657-667
17 Grunenwald D, Spaggiari L, Girard P h. Baldeyrou P, Filaire M, Dennewald G. Completion pneumonectomy for lung metastases: is it justified?. Eur J Cardiothorac Surg. 1997; 12 694-697
18 Weksler B, Burt M. Isolated lung perfusion with antineoplastic agents for pulmonary metastases. In: Faber LP, McCormack PM eds. Chest Surgery Clinics of North America. Metastatic disease to the lung. Pennsylvania: W.B. Saunders. 1998; 8 157-182
19 Hendriks J M. Pulmonary metastases. Therapeutic Application of Isolated Lung Perfusion. PhD Thesis, Antwerp University 2001
20 Burt M, Liu D, Abolhoda A. et al . Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg. 2000; 69 1542-1549

Dr. J. Hendriks

Department of Thoracic and Vascular Surgery, University Hospital Antwerp (UZA)

Wilrijkstraat 10

2650 Edegem

Belgium

Phone: +32 (3) 821 31 48

Fax: +32 (3) 825 13 08

Email: jeroen.hendriks@uza.be